SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001818382-22-000195
Filing Date
2022-12-12
Accepted
2022-12-12 16:04:22
Documents
14
Period of Report
2022-12-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K huma-20221208.htm   iXBRL 8-K 42725
2 EX-3.2 huma-20221208xexhibit32.htm EX-3.2 184758
  Complete submission text file 0001818382-22-000195.txt   449010

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT huma-20221208.xsd EX-101.SCH 2299
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT huma-20221208_def.xml EX-101.DEF 16410
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT huma-20221208_lab.xml EX-101.LAB 31802
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT huma-20221208_pre.xml EX-101.PRE 17148
8 EXTRACTED XBRL INSTANCE DOCUMENT huma-20221208_htm.xml XML 15078
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39532 | Film No.: 221457160
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences